Bay City Capital LLC, European Office Basel

https://www.baycitycapital.com

Bay City Capital is a life sciences venture capital firm investing in opportunities across the various life sciences sectors in companies at all stages of development. Established in 1997, the firm has managed eight venture capital funds representing over $1.6 billion in capital commitments. Bay City Capital has invested in over 100 life sciences companies globally, including Epizyme, Epocrates, GenturaDx, Hyperion Therapeutics, Ion Torrent Systems, Lexicon, MAP Pharmaceuticals, Medarex, Nabsys, NextWave Pharmaceuticals, Oculex Pharmaceuticals, Pharmion, Reliant Pharmaceuticals, and Sunesis Pharmaceuticals. *

	Start	2013-10-06 existent
	Group	Bay City Capital LLC
	Industry	investment banking
	Industry 2	LIFE SCIENCES
	Person	Carnot, Lionel (EarlyBird 202010 Partner + Bay City Capital 201608 Managing Director)

	Region	Basel BS
	Country	Switzerland
	Street	22 Steinengraben Suite 4.12
	City	4051 Basel
	Tel	+41-61-500-1621
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Merus B.V.. (10/3/13). "Press Release: Merus Secures €31 Million in Series B Round Extension. Investment Brings Series B to a Total of €47.6 Million". Utrecht.

		Record changed: 2019-01-08

More documents for Bay City Capital LLC

[1] Oculis S.A.. (1/4/18). "Press Release: Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases". Lausanne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)